During the past decade, Xixi hospital of Hangzhou conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Xixi hospital of Hangzhou" #1 sponsor was "Nanfang Hospital of Southern Medical University" with 4 trials, followed by "Beijing Friendship Hospital" with 1 trials sponsored, "Beijing Kawin Technology Share-Holding Co., Ltd." with 1 trials sponsored, "HeNan Sincere Biotech Co., Ltd" with 1 trials sponsored and "Jiangsu Hansoh Pharmaceutical Co., Ltd." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Xixi hospital of Hangzhou" #1 collaborator was "Tigermed Consulting Co., Ltd" with 2 trials as a collaborator, "Xixi Hospital of Hangzhou" with 2 trials as a collaborator, "Beijing Ditan Hospital" with 1 trials as a collaborator, "Beijing Tiantan Hospital" with 1 trials as a collaborator and "Beijing YouAn Hospital" with 1 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Xixi hospital of Hangzhou" are "Hepatitis B, Chronic" (3 trials), "Chronic Hepatitis B" (2 trials), "Mother to Child Transmission" (2 trials), "Chronic Hepatitis" (1 trials) and "Chronic Hepatitis C" (1 trials). Many other conditions were trialed in "Xixi hospital of Hangzhou" in a lesser frequency.

Most popular intervention types in "Xixi hospital of Hangzhou" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "3TC" (1 trials), "3TC placebo" (1 trials), "Adefovir" (1 trials), "B/F/TAF" (1 trials) and "EFV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Xixi hospital of Hangzhou" are 9 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Xixi hospital of Hangzhou". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Xixi hospital of Hangzhou, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Xixi hospital of Hangzhou, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".